Renoprotective role of ACE inhibitors in diabetic nephropathy
- 1 September 1994
- Vol. 72 (3 Suppl) , S38-S45
- https://doi.org/10.1136/hrt.72.3_suppl.s38
Abstract
No abstract availableThis publication has 71 references indexed in Scilit:
- Captopril or conventional therapy in hypertensive type II diabetics. Three-year analysis.Hypertension, 1993
- Comparison of reduction in microalbuminuria by enalapril and hydrochlorothiazide in normotensive patients with insulin dependent diabetes.BMJ, 1993
- Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis.BMJ, 1992
- Angiotensin converting enzyme inhibitors and diabetic nephropathy.BMJ, 1992
- Beneficial effect of alacepril, a new angiotensin-converting enzyme inhibitor on albuminuria and glycemic state: An open multicenter trialJournal of Diabetic Complications, 1991
- Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patientsDiabetologia, 1991
- Angiotensin converting enzyme inhibitor therapy to decrease microalbuminuria in normotensive children with insulin-dependent diabetes mellitusThe Journal of Pediatrics, 1990
- Microalbuminuria and ACE inhibition in non-hypertensive diabeticsJournal of Diabetic Complications, 1990
- Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.BMJ, 1988
- Effect of Captopril on Heavy Proteinuria in Azotemic DiabeticsNew England Journal of Medicine, 1985